Immuvera Therapeutics
PrivateLast Round
Crowdfunding
Jan 15, 2026
Est. Valuation
$12.8M
Total Funding Raised
$2.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Immuvera Therapeutics operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Crowdfunding round in January 2026.
Immuvera Therapeutics is a biotechnology company that develops innovative, cost-effective cancer immunotherapies for companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immuvera Therapeutics Comparables
Compare Immuvera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evvivax | 82% | |
| LEAH Labs | 79% | |
| Vetigenics Inc. | 77% |
For institutional investors. Book with your work email.
Immuvera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jan 15, 2026 | ||||
| Crowdfunding | Jan 15, 2026 | ||||
| Crowdfunding | Feb 21, 2023 | ||||
| Crowdfunding | Apr 13, 2022 |
For institutional investors. Book with your work email.
Immuvera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sarsia | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Completed a crowdfunding round of funding.
- Feb 21, 2023
Raised $880K in a crowdfunding round.
For institutional investors. Book with your work email.
Immuvera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immuvera Therapeutics's valuation, stock price, and market status.
Is Immuvera Therapeutics a public or private company?
Immuvera Therapeutics is a private company.
What is the current stock price of Immuvera Therapeutics?
Immuvera Therapeutics is a private company, so its shares have no public market price. Caplight tracks Immuvera Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immuvera Therapeutics worth (valuation)?
Immuvera Therapeutics's valuation is estimated at $12.8M based on funding round data.
Can I buy Immuvera Therapeutics stock?
Immuvera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immuvera Therapeutics's last funding round?
Immuvera Therapeutics's most recent funding round was Crowdfunding on January 15, 2026.
Who are the main investors in Immuvera Therapeutics?
Key investors in Immuvera Therapeutics include Sarsia.
Will Immuvera Therapeutics IPO soon?
No public IPO plans have been announced for Immuvera Therapeutics.
How can I track Immuvera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Immuvera Therapeutics's shares on secondary markets.